8-K: Nordson Corporation Reports Record Fiscal Year 2024 Sales, Provides 2025 Outlook

Nordson Corporation announced record sales for fiscal year 2024, driven by acquisitions, while also providing a conservative outlook for fiscal year 2025.

Summary

• Nordson Corporation reported fourth quarter sales of $744 million, a 4% increase year-over-year, with a 6% positive impact from acquisitions and 1% from currency translation, offset by a 3% organic sales decrease.
• Full year sales reached a record $2.7 billion, a 2% increase over the previous year, with a 5% boost from acquisitions and a 3% decrease in organic volume.
• Fourth quarter earnings per diluted share were $2.12, while adjusted earnings per diluted share were $2.78.
• Full year earnings per diluted share were $8.11, and adjusted earnings per diluted share were $9.73.
• EBITDA for the full year was a record $849 million, up 4% year-over-year, representing 32% of sales.
• The company forecasts fiscal year 2025 sales to be between $2.75 billion and $2.87 billion, with adjusted earnings per diluted share between $9.70 and $10.50.
• First quarter fiscal 2025 sales are projected to be in the range of $615 to $655 million, with adjusted earnings per diluted share between $1.95 and $2.15.

Sentiment

Score: 7

Explanation: The sentiment is positive due to record sales and strong EBITDA, but tempered by a conservative outlook and some organic sales declines. The company is performing well but is cautious about the future.

Positives

• The company's diversified portfolio and leadership in niche markets are delivering balanced results.
• The acquisition strategy is generating growth.
• Nordson is generating strong free cash flow, allowing for reinvestment and shareholder returns.
• The NBS Next growth framework is being successfully integrated and deployed.
• The company's direct sales model and applications expertise are serving global customers effectively.

Negatives

• Organic sales decreased by 3% in the fourth quarter and 3% for the full year.
• Net income for the full year decreased to $467 million from $487 million in the prior year.
• Adjusted earnings per diluted share for the full year decreased to $9.73 from $9.85 in the prior year.
• The Industrial Precision Solutions segment experienced a 3% sales decrease in the fourth quarter.
• The Medical and Fluid Solutions segment saw a 3% organic sales decrease in the fourth quarter.

Risks

• The company is facing challenges from the evolving global macro-environment.
• There is uncertainty regarding the timing of end market recovery, particularly in electronics and agriculture.
• The first fiscal quarter is seasonally the weakest due to holiday and year-end slowdowns.
• The company is exposed to risks related to U.S. and international economic conditions, currency exchange rates, and possible acquisitions.

Future Outlook

Nordson anticipates fiscal 2025 sales in the range of $2.75 billion to $2.87 billion and adjusted earnings per diluted share in the range of $9.70 to $10.50. First quarter fiscal 2025 sales are forecasted between $615 and $655 million with adjusted earnings between $1.95 and $2.15 per diluted share.

Management Comments

• Nordson President and CEO Sundaram Nagarajan stated that the team delivered results above fourth quarter guidance expectations.
• Nagarajan highlighted the strong performance of the Advanced Technology Solutions segment and the early integration of the Atrion Medical acquisition.
• Nagarajan noted that the company is entering 2025 with a conservative viewpoint due to the evolving global macro-environment.
• Management is confident about the long-term growth drivers of their end markets but is being prudent about expectations for end market recovery timing.

Industry Context

Nordson's results reflect a mixed performance in a complex global economic environment, with strong growth in some segments offset by declines in others. The company's focus on acquisitions and niche markets aligns with broader industry trends of consolidation and specialization. The conservative outlook for 2025 suggests caution in the face of macroeconomic uncertainty, which is a common theme among industrial companies.

Comparison to Industry Standards

• Nordson's 2% sales growth for the year is moderate compared to some high-growth technology companies, but is solid for a diversified industrial company.
• The 32% EBITDA margin is strong and indicates good profitability, placing Nordson among the leaders in its sector.
• Companies like Illinois Tool Works (ITW) and Dover Corporation are comparable in terms of diversified industrial operations, and Nordson's performance is in line with their typical results.
• The 105% free cash flow conversion rate is excellent, indicating efficient capital management, and is better than many of its peers.
• The company's focus on niche markets and differentiated products is a strategy also employed by companies like Roper Technologies, which has seen success with this approach.

Stakeholder Impact

• Shareholders will be pleased with the record sales and strong cash flow, but may be concerned about the conservative outlook.
• Employees will likely be motivated by the company's success and growth, but may be aware of the challenges in the macro-environment.
• Customers will benefit from the company's continued investment in innovation and customer service.
• Suppliers will see continued business with a stable and growing company.
• Creditors will be reassured by the company's strong financial performance and cash flow.

Next Steps

• Nordson management will provide additional commentary on the results and outlook during a webcast on December 12, 2024.
• The company will continue to focus on integrating the Atrion Medical acquisition and deploying the NBS Next growth framework.
• Nordson will monitor the evolving global macro-environment and adjust its strategies as needed.

Key Dates

Keywords

Nordson, sales, EBITDA, earnings, acquisitions, financial results, fiscal year, organic growth, free cash flow, guidance